Table 2

Patient characteristics, comorbidities and causes of death

Variable (SD)CAER=1
N=329
CAER=2,3,4
N=25
P value
Age, mean (SD)77.8 (12.6)77.4 (14.4)0.91
Female sex, no. (%)159 (48)11 (44)0.70
Goals of care on admission, no. (%)0.07
 R180 (24)9 (36)
 R26 (2)2 (8)
 R321 (6)1 (4)
 M1194 (59)10 (40)
 M212 (4)3 (12)
 C111 (3)0 (0)
 C25 (2)0 (0)
Goals of care on death, no. (%)0.10
 R111 (3)1 (4)
 R21 (0.3)1 (4)
 R36 (2)0 (0)
 M154 (16)7 (28)
 M23 (0.9)1 (4)
 C1184 (56)10 (40)
 C270 (21)5 (20)
Cause of death0.72
 Cancer61 (19)3 (12)
 Cardiac40 (12)5 (20)
 Chronic obstructive pulmonary disease2 (0.6)0 (0)
 COVID53 (16)6 (24)
 Non-COVID infection92 (28)7 (28)
 Stroke8 (2)0 (0)
 Other73 (22)4 (16)
CAER score
 1329 (100)0 (0)
 20 (0)11 (44)
 30 (0)7 (28)
 40 (0)7 (28)
Length of stay (LOS), mean (SD)11.1 (12.5)15.7 (11.3)0.06
Charlson Comorbidity Index, mean (SD)7.6 (2.7)7.3 (2.9)0.63
Myocardial infarction, no. (%)86 (26)10 (400.13
Heart failure, no. (%)110 (33)9 (36)0.79
Peripheral vascular disease, no. (%)28 (9)6 (24)0.02
Cerebrovascular disease, no. (%)64 (19)7 (28)0.30
Dementia, no. (%)106 (32)6 (24)0.39
Chronic obstructive pulmonary disease, no. (%)97 (29)8 (32)0.79
Connective tissue disease, no. (%)29 (9)1 (4)0.71
Peptic ulcer disease, no. (%)30 (9)3 (12)0.72
Liver disease, no. (%)32 (10)3 (12)0.72
Diabetes, no. (%)67 (20)2 (8)0.19
End-stage renal failure, no. (%)22 (7)2 (8)0.68
Cancer, no. (%)135 (41)8 (32)0.37
HIV, no. (%)2 (0.6)0 (0)
  • CAER, clinical adverse event rating .